Felodipine
"Felodipine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
Descriptor ID |
D015736
|
MeSH Number(s) |
D03.383.725.203.250
|
Concept/Terms |
Felo-Puren- Felo-Puren
- Felo Puren
- Alpharma Brand of Felodipine
Felobeta- Felobeta
- betapharm Brand of Felodipine
Felocor- Felocor
- Hexal Brand of Felodipine
Felodur- Felodur
- Alphapharm Brand of Felodipine
Fensel- Fensel
- Pharmacia Spain Brand of Felodipine
Plendil- Plendil
- Promed Brand of Felodipine
- Flodil
- Modip
- Astra Brand of Felodipine
- AstraZeneca Brand of Felodipine
Renedil- Renedil
- Hoechst Brand of Felodipine
- Munobal
- Aventis Brand of Felodipine
felodipin von ct- felodipin von ct
- ct-Arzneimittel Brand of Felodipine
- ct Arzneimittel Brand of Felodipine
Perfudal- Perfudal
- Pharmaceutica Astra Brand of Felodipine
Agon- Agon
- TheraPharm Brand of Felodipine
|
Below are MeSH descriptors whose meaning is more general than "Felodipine".
Below are MeSH descriptors whose meaning is more specific than "Felodipine".
This graph shows the total number of publications written about "Felodipine" by people in this website by year, and whether "Felodipine" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 2 | 0 | 2 | 2001 | 1 | 0 | 1 | 2004 | 1 | 0 | 1 | 2014 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Felodipine" by people in Profiles.
-
Chattoraj S, Bhugra C, Li ZJ, Sun CC. Effect of heating rate and kinetic model selection on activation energy of nonisothermal crystallization of amorphous felodipine. J Pharm Sci. 2014 Dec; 103(12):3950-3957.
-
Menzin J, Lang K, Elliott WJ, Boulanger L, Arocho R, Tran MH, Friedman M. Adherence to calcium channel blocker therapy in older adults: a comparison of amlodipine and felodipine. J Int Med Res. 2004 May-Jun; 32(3):233-9.
-
Black HR, Elliott WJ, Weber MA, Frishman WH, Strom JA, Liebson PR, Hwang CT, Ruff DA, Montoro R, DeQuattro V, Zhang D, Schleman MM, Klibaner MI. One-year study of felodipine or placebo for stage 1 isolated systolic hypertension. Hypertension. 2001 Nov; 38(5):1118-23.
-
Elliott WJ, Montoro R, Smith D, Leibowitz M, Hwang C, Gradman AH, Schleman M, Klibaner M. Comparison of two strategies for intensifying antihypertensive treatment: low-dose combination (enalapril + felodipine ER) versus increased dose of monotherapy (enalapril). LEVEL (Lexxel vs Enalapril) Study Group. Am J Hypertens. 1999 Jul; 12(7):691-6.
-
Griffin KA, Picken MM, Bakris GL, Bidani AK. Class differences in the effects of calcium channel blockers in the rat remnant kidney model. Kidney Int. 1999 May; 55(5):1849-60.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|